Research
8 results.
GRAND RAPIDS, Mich. (April 14, 2025) — Aging is the most important risk factor for neurodegenerative diseases, including Parkinson’s disease. However, the connection between aging…
Earlier this week, The Lancet published results of a phase 3 clinical trial that explored whether the Type 2 diabetes medication exenatide could…
GRAND RAPIDS, Mich. (Dec. 20, 2024) — Van Andel Institute has appointed leading Parkinson’s scientist Darren Moore, Ph.D., as the Jay Van Andel Endowed Chair in…
Collaboration, innovation and robust science are a powerful combination, one that drives discoveries aimed at improving health for generations to come. The era of siloed…
London, United Kingdom (Jan. 10, 2023) — Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol,…
GRAND RAPIDS, Mich. (Sept. 21, 2020) — A collaborative team between the University of Minnesota Medical School and Van Andel Institute (VAI) will soon begin…
Many diseases and disorders studied at Van Andel Institute have genetic links, including cancer and Parkinson’s disease. Gene mutations, or changes to genes, play a…
In honor of Parkinson’s Awareness Month and the 200th anniversary of Dr. James Parkinson’s An Essay on the Shaking Palsy, we asked scientists in…